Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.

CompletedOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions

Genetic Predisposition

Trial Locations (1)

King Hussein Cancer Center, Amman

All Listed Sponsors

lead

King Hussein Cancer Center

OTHER